Works matching AU Feifei Nan

Results: 27

Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial.

Published in:

Journal of Neuro-Oncology, 2018, v. 140, n. 2, p. 427, doi. 10.1007/s11060-018-2970-x

By:

Wu, Jingjing;
Duan, Lingling;
Zhang, Lei;
Sun, Zhenchang;
Fu, Xiaorui;
Li, Xin;
Li, Ling;
Wang, Xinhua;
Zhang, Xudong;
Li, Zhaoming;
Yu, Hui;
Chang, Yu;
Nan, Feifei;
Yan, Jiaqin;
Tian, Li;
Wang, Xiaoli;
Zhang, Mingzhi

Publication type:

Article

Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients.

Published in:

Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920923829

By:

Sun, Yuanyuan;
Li, Ling;
Li, Xin;
Zhang, Lei;
Wang, Xinhua;
Fu, Xiaorui;
Sun, Zhenchang;
Zhang, Xudong;
Li, Zhaoming;
Wu, Jingjing;
Yu, Hui;
Chang, Yu;
Yan, Jiaqin;
Wu, Xiaolong;
Zhou, Zhiyuan;
Nan, Feifei;
Tian, Li;
Zhang, Mingzhi

Publication type:

Article

Increased expression of microRNA-503 and reduced expression of kangai-1 in B-cell non-Hodgkin's lymphoma.

Published in:

Experimental & Therapeutic Medicine, 2016, v. 11, n. 3, p. 917, doi. 10.3892/etm.2016.2971

By:

JINGJING WU;
AIMIN LI;
PENGYU ZHANG;
ZHENCHANG SUN;
LIJUAN HAN;
FEIFEI NAN;
LI GENG

Publication type:

Article

Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma.

Published in:

Leukemia & Lymphoma, 2023, v. 64, n. 3, p. 605, doi. 10.1080/10428194.2023.2167492

By:

Lin, Meng;
Wu, Xiaolong;
Zhang, Lei;
Li, Ling;
Wang, Xinhua;
Fu, Xiaorui;
Sun, Zhenchang;
Zhang, Xudong;
Zhu, Linan;
Yu, Hui;
Chang, Yu;
Nan, Feifei;
Yan, Jiaqin;
Zhou, Zhiyuan;
Shi, Cunzhen;
Zhang, Mingzhi;
Li, Xin

Publication type:

Article

Improving outcomes in limited-stage de novo CD5+ DLBCL: systemic approaches with consolidative radiation.

Published in:

Leukemia & Lymphoma, 2022, v. 63, n. 6, p. 1369, doi. 10.1080/10428194.2021.2023742

By:

Ge, Jurui;
Xia, Yaqin;
Sun, Zhenchang;
Zhang, Lei;
Li, Xin;
Li, Ling;
Wang, Xinhua;
Zhang, Xudong;
Li, Zhaoming;
Nan, Feifei;
Wan, Wenjuan;
Xu, Duo;
Ding, Jiayin;
Fu, XiaoRui;
Zhang, Mingzhi

Publication type:

Article

Safety and efficacy of low-dose pre-phase before conventional-dose chemotherapy for ulcerative gastric diffuse large B-cell lymphoma.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 9, p. 2613, doi. 10.3109/10428194.2015.1014366

By:

Cui, Yingying;
Li, Xin;
Sun, Zhenchang;
Leng, Changsen;
Young, Ken;
Wu, Xiaolong;
Zhang, Lei;
Fu, Xiaorui;
Li, Ling;
Zhang, Xudong;
Chang, Yu;
Nan, Feifei;
Li, Zhaoming;
Yan, Jiaqin;
Zhou, Zhiyuan;
Zhang, Mingzhi;
Li, Wencai;
Wang, Guannan;
Zhang, Dandan

Publication type:

Article

Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study.

Published in:

Drug Design, Development & Therapy, 2020, v. 14, p. 275, doi. 10.2147/DDDT.S227477

By:

Ma, Xinran;
Li, Ling;
Zhang, Lei;
Fu, Xiaorui;
Li, Xin;
Wang, Xinhua;
Wu, Jingjing;
Sun, Zhenchang;
Zhang, Xudong;
Feng, Xiaoyan;
Chang, Yu;
Zhou, Zhiyuan;
Nan, Feifei;
Zhang, Jieming;
Li, Zhaoming;
Zhang, Mingzhi

Publication type:

Article

Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?.

Published in:

Cancer Cell International, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12935-018-0644-6

By:

Zhang, Xudong;
Fu, Xiaorui;
Dong, Meng;
Yang, Zhenzhen;
Wu, Shaoxuan;
Ma, Mijing;
Li, Zhaoming;
Wang, Xinhua;
Li, Ling;
Li, Xin;
Sun, Zhenchang;
Chang, Yu;
Nan, Feifei;
Yan, Jiaqin;
Mao, Yun;
Zhang, Mingzhi;
Chen, Qingjiang

Publication type:

Article

Clinical analysis of patients with primary and secondary extranodal natural killer/T‐cell lymphoma of central nervous system.

Published in:

Hematological Oncology, 2023, v. 41, n. 2, p. 267, doi. 10.1002/hon.2894

By:

Li, Xingying;
Yu, Hui;
Fu, Xiaorui;
Zhang, Lei;
Li, Xin;
Li, Ling;
Wang, Xinhua;
Sun, Zhenchang;
Zhang, Xudong;
Li, Zhaoming;
Wu, Jingjing;
Chang, Yu;
Yan, Jiaqin;
Zhou, Zhiyuan;
Nan, Feifei;
Wu, Xiaolong;
Tian, Li;
Zhang, Mingzhi

Publication type:

Article

The clinical characteristics and prognostic factors of 410 patients with natural killer/T-cell lymphoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 12, p. 3449, doi. 10.1007/s00432-022-04203-x

By:

Sun, Zhenchang;
Wan, Wenjuan;
Zhang, Xudong;
Zhang, Lei;
Li, Xin;
Li, Ling;
Wang, Xinhua;
Nan, Feifei;
Yu, Hui;
Chang, Yu;
Yan, Jiaqin;
Li, Zhaoming;
Cui, Fangfang;
Ge, Jurui;
XiaXu, Yaqin Duo;
Xu, Xia;
Fu, Xiaorui;
Zhang, Mingzhi

Publication type:

Article

MicroRNA expression analysis of mammospheres cultured from human breast cancers.

Published in:

Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 11, p. 1937, doi. 10.1007/s00432-012-1272-5

By:

Feifei, Nan;
Mingzhi, Zhang;
Yanyun, Zhang;
Huanle, Zhang;
Fang, Ren;
Mingzhu, Huang;
Mingzhi, Cao;
Yafei, Shi;
Fengchun, Zhang

Publication type:

Article

MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1.

Published in:

Cancer Biology & Therapy, 2019, v. 20, n. 1, p. 31, doi. 10.1080/15384047.2018.1504721

By:

Chang, Yu;
Cui, Meng;
Fu, Xiaorui;
Zhang, Lei;
Li, Xin;
Li, Ling;
Wu, Jingjing;
Sun, Zhenchang;
Zhang, Xudong;
Li, Zhaoming;
Nan, Feifei;
Yan, Jiaqin;
Zhang, Mingzhi

Publication type:

Article

Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial.

Published in:

Cancer Biology & Medicine, 2022, v. 19, n. 7, p. 1089, doi. 10.20892/j.issn.2095-3941.2021.0026

By:

Jingjing Wu;
Fenghua Gao;
Wenhua Wang;
Xudong Zhang;
Meng Dong;
Lei Zhang;
Xin Li;
Ling Li;
Zhenchang Sun;
Xinhua Wang;
Xiaorui Fu;
Linan Zhu;
Mengjie Ding;
Songtao Niu;
Zhaoming Li;
Yu Chang;
Feifei Nan;
Jiaqian Yan;
Hui Yu;
Xiaolong Wu

Publication type:

Article

Effective Treatment with PD-1 Antibody, Chidamide, Etoposide, and Thalidomide (PCET) for Relapsed/Refractory Natural Killer/T-Cell Lymphoma: A Report of Three Cases.

Published in:

OncoTargets & Therapy, 2020, v. 13, p. 7189, doi. 10.2147/OTT.S262039

By:

Du, Lijun;
Zhang, Lei;
Li, Ling;
Li, Xin;
Yan, Jiaqin;
Wang, Xinhua;
Fu, Xiaorui;
Sun, Zhenchang;
Zhang, Xudong;
Li, Zhaoming;
Wu, Jingjing;
Yu, Hui;
Chang, Yu;
Zhou, Zhiyuan;
Nan, Feifei;
Wu, Xiaolong;
Tian, Li;
Zhang, Mingzhi

Publication type:

Article

Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical study.

Published in:

Cancer Management & Research, 2019, v. 11, p. 1363, doi. 10.2147/CMAR.S192143

By:

Ma, Qianwen;
Chang, Yu;
Li, Ling;
Li, Xin;
Wang, Xinhua;
Wu, Jingjing;
Fu, Xiaorui;
Sun, Zhenchang;
Yu, Hui;
Zhang, Xudong;
Zhou, Zhiyuan;
Nan, Feifei;
Li, Zhaoming;
Liu, Xiyang;
Zhao, Qian;
Li, Yang;
Zhang, Lan;
Zhang, Mingzhi;
Zhang, Lei

Publication type:

Article

The Relationship Between Internal Motor Imagery and Motor Inhibition in School-Aged Children: A Cross-Sectional Study.

Published in:

Advances in Cognitive Psychology, 2021, v. 17, n. 1, p. 88, doi. 10.5709/acp-0319-9

By:

Cuiping Wang;
Wei Li;
Yanlin Zhou;
Feifei Nan;
Guohua Zhao;
Qiong Zhang

Publication type:

Article

Lymphoma associated hemophagocytic syndrome: A single-center retrospective study.

Published in:

Oncology Letters, 2018, v. 16, n. 1, p. 1275, doi. 10.3892/ol.2018.8783

By:

Chang, Yu;
Cui, Meng;
Fu, Xiaorui;
Han, Lijuan;
Zhang, Lei;
Li, Ling;
Li, Xin;
Sun, Zhenchang;
Wu, Jingjing;
Zhang, Xudong;
Li, Zhaoming;
Nan, Feifei;
Yan, Jiaqin;
Sheng, Guangyao;
Zhang, Mingzhi

Publication type:

Article

Penile metastasis secondary to nasal-type extranodal natural killer/T-cell lymphoma: A case report and review of the literature.

Published in:

2018

By:

Li, Yanan;
Fu, Xiaorui;
Wu, Jingjing;
Yu, Chang;
Li, Zhaoming;
Sun, Zhenchang;
Yan, Jiaqin;
Nan, Feifei;
Zhang, Xundong;
Li, Ling;
Li, Xin;
Zhang, Lei;
Li, Wencai;
Wang, Guannan;
Zhang, Mingzhi

Publication type:

Case Study

Expression and clinical significance of cyclooxygenase-2 and interleukin-32 in primary gastric B-cell lymphoma.

Published in:

Oncology Letters, 2016, v. 11, n. 1, p. 693, doi. 10.3892/ol.2015.3950

By:

YINGYING CUI;
ZHENCHANG SUN;
XIN LI;
CHANGSEN LENG;
LEI ZHANG;
XIAORUI FU;
LING LI;
XUDONG ZHANG;
YU CHANG;
FEIFEI NAN;
ZHAOMING LI;
JIAQIN YAN;
MINGZHI ZHANG;
WENCAI LI;
GUANNAN WANG;
DANDAN ZHANG;
YAOZHEN MA

Publication type:

Article

Breast cancer stromal fibroblasts promote the generation of CD44+CD24-cells through SDF-1/CXCR4 interaction.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2010, v. 29, p. 80, doi. 10.1186/1756-9966-29-80

By:

Mingzhu Huang;
Yuqing Li;
Huanle Zhang;
Feifei Nan

Publication type:

Article

Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis‐like T‐cell lymphoma.

Published in:

2018

By:

Li, Zhaoming;
Lu, Lisha;
Zhou, Zhiyuan;
Xue, Weili;
Wang, Yingjun;
Jin, Mengyuan;
Qiu, Yajuan;
Sun, Wei;
Fu, Xuefei;
Zhang, Xudong;
Chang, Yu;
Nan, Feifei;
Yan, Jiaqin;
Wang, Guannan;
Sun, Zhenchang;
Fu, Xiaorui;
Li, Ling;
Li, Xin;
Wang, Xinhua;
Wu, Jingjing

Publication type:

Letter to the Editor

The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers.

Published in:

British Journal of Haematology, 2017, v. 178, n. 5, p. 772, doi. 10.1111/bjh.14763

By:

Li, Ling;
Duan, Wenjing;
Zhang, Lei;
Li, Xin;
Fu, Xiaorui;
Wang, Xinhua;
Wu, Jingjing;
Sun, Zhenchang;
Zhang, Xudong;
Chang, Yu;
Nan, Feifei;
Yan, Jiaqin;
Li, Zhaoming;
Young, Ken H.;
Zhang, Mingzhi

Publication type:

Article

Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T‐cell lymphoma: A randomized, controlled, open‐label, multicenter study.

Published in:

International Journal of Cancer, 2021, v. 148, n. 6, p. 1470, doi. 10.1002/ijc.33329

By:

Zhang, Lei;
Wang, Yan;
Li, Xin;
Li, Ling;
Wang, Xinhua;
Sun, Zhenchang;
Wu, Jingjing;
Fu, Xiaorui;
Zhang, Xudong;
Yu, Hui;
Wang, Guannan;
Chang, Yu;
Yan, Jiaqin;
Zhou, Zhiyuan;
Wu, Xiaolong;
Nan, Feifei;
Li, Wencai;
Zhang, Mingzhi

Publication type:

Article

AEG-1 is involved in hypoxia-induced autophagy and decreases chemosensitivity in T-cell lymphoma.

Published in:

Molecular Medicine, 2018, v. 24, n. 1, p. N.PAG, doi. 10.1186/s10020-018-0033-6

By:

Yan, Jiaqin;
Zhang, Junhui;
Zhang, Xudong;
Li, Xin;
Li, Ling;
Li, Zhaoming;
Chen, Renyin;
Zhang, Lei;
Wu, Jingjing;
Wang, Xinhua;
Sun, Zhenchang;
Fu, Xiaorui;
Chang, Yu;
Nan, Feifei;
Yu, Hui;
Wu, Xiaolong;
Feng, Xiaoyan;
Li, Wencai;
Zhang, Mingzhi

Publication type:

Article

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma.

Published in:

Journal of Hematology & Oncology, 2018, v. 11, p. 1, doi. 10.1186/s13045-018-0559-7

By:

Li, Xin;
Cheng, Yasong;
Zhang, Mingzhi;
Yan, Jiaqin;
Li, Ling;
Fu, Xiaorui;
Zhang, Xudong;
Chang, Yu;
Sun, Zhenchang;
Yu, Hui;
Zhang, Lei;
Wang, Xinhua;
Wu, Jingjing;
Li, Zhaoming;
Nan, Feifei;
Tian, Li;
Li, Wencai;
Young, Ken H.

Publication type:

Article

Strategies to overcome CAR-T cell resistance in clinical work: A single-institute experience.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.929221

By:

Feifei Nan;
Xiaorui Fu;
Xinfeng Chen;
Ling Li;
Xin Li;
Jingjing Wu;
Xiaoyan Feng;
Xiaolong Wu;
Jiaqin Yan;
Mingzhi Zhang

Publication type:

Article

Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma.

Published in:

Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12032-9

By:

Li, Zhaoming;
Zhang, Xudong;
Xue, Weili;
Zhang, Yanjie;
Li, Chaoping;
Song, Yue;
Mei, Mei;
Lu, Lisha;
Wang, Yingjun;
Zhou, Zhiyuan;
Jin, Mengyuan;
Bian, Yangyang;
Zhang, Lei;
Wang, Xinhua;
Li, Ling;
Li, Xin;
Fu, Xiaorui;
Sun, Zhenchang;
Wu, Jingjing;
Nan, Feifei

Publication type:

Article